Delaware Senate Bill 45 (Prior Session Legislation)

---

Completed Legislative Action
Spectrum: Bipartisan Bill
Status: Passed on July 17 2017 - 100% progression
Action: 2017-07-17 - Signed by Governor
Text: Latest bill text (Draft #1) [HTML]

This Bill adds 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700) to Schedule I of the Uniform Controlled Substances Act. U-47700, also known as Pink, is a synthetic opioid recently encountered by law enforcement and public health officials and is being abused for its opioid properties. It is available over the Internet and is marketed as a research chemical. The safety risks to users are significant and the public health risks include large numbers of drug treatment admissions, emergency room visits and fatal overdoses. On November 14, 2016, the Federal Drug Enforcement Agency temporarily placed U-47700 in Schedule I for a two-year period, finding that this synthetic opioid has a high potential for abuse, no currently accepted medical use in treatment in the United States and lacks accepted safety for use under medical supervision. By Emergency Order dated December 15, 2016, the Secretary of State temporarily placed U-47700 in Schedule I. This Order is effective for 120 days. The permanent addition of U-47700 to Schedule I is required in the interest of public protection.

An Act To Amend Title 16 Of The Delaware Code Relating To The Uniform Controlled Substances Act.

Sen. Bryan Townsend [D]	Rep. David Bentz [D]	Sen. Stephanie Hansen [D]	Sen. Gerald Hocker [R]
Sen. Ernesto Lopez [R]	Rep. Ruth Briggs King [R]	Rep. Debra Heffernan [D]	Rep. Deborah Hudson [R]
Rep. Helene Keeley [D]	Rep. Joseph Miro [R]	Sen. Charles Paradee [D]	Rep. Kimberly Williams [D]

2017-05-18 - House - House Third Reading (Y: 40 N: 0 NV: 0 Abs: 1) [PASS]
2017-04-26 - Senate - Senate Third Reading (Y: 20 N: 0 NV: 0 Abs: 1) [PASS]
2017-04-26 - Senate - Senate Third Reading (Y: 20 N: 0 NV: 0 Abs: 1) [PASS]

Date	Chamber	Action
2017-07-17		Signed by Governor
2017-05-18		Passed By House. Votes: 40 YES 1 ABSENT
2017-05-03		Reported Out of Committee (Health & Human Development) in House with 9 On Its Merits
2017-04-27		Assigned to Health & Human Development Committee in House
2017-04-26		Passed By Senate. Votes: 20 YES 1 ABSENT
2017-04-26		Passed By Senate. Votes: 20 YES 1 ABSENT
2017-04-05		Reported Out of Committee (Health, Children & Social Services) in Senate with 3 On Its Merits
2017-03-30		Introduced and Assigned to Health, Children & Social Services Committee in Senate

Type	Source
Summary	http://legis.delaware.gov/BillDetail?LegislationId=25565
Text	http://legis.delaware.gov/json/BillDetail/GenerateHtmlDocument?legislationId=25565&legislationTypeId=1&docTypeId=2&legislationName=SB45
Roll Call	http://legis.delaware.gov/json/RollCall/GetRollCallVoteByRollCallId#18486
Roll Call	http://legis.delaware.gov/json/RollCall/GetRollCallVoteByRollCallId#18485
Roll Call	http://legis.delaware.gov/json/RollCall/GetRollCallVoteByRollCallId#18688